Skip to main content

Table 3 Significant differentially expressed probesets from five ExpG eyes compared to eight control eyes by microarray.

From: Bioinformatic and statistical analysis of the optic nerve head in a primate model of ocular hypertension

PROBESET

Definition

Group fold change

Representative public ID

Gene title

Gene symbol

RP

SAM

ONH astrocyte

RGC

Hs.103291

HS, PT

1.79 ± 0.68

NM_016588

neuritin 1

NRN1

0.00

0.01

NA

Y

Hs.12333

HS, PT

-1.69 ± 0.25

NM_007282

ring finger protein 13

RNF13

0.03

0.01

Y

NA

Hs.134974

HS, PT

1.70 ± 0.37

NM_002045

growth associated protein 43

GAP43

0.06

0.01

N

Y

Hs.155097

HS, PT

-1.62 ± 0.49

M36532

carbonic anhydrase II

CA2

0.05

0.11

N

NA

Hs.155247

HS

-2.37 ± 0.94

NM_005165

aldolase C, fructose-bisphosphate

ALDOC

0.00

0.01

Y

Y

Hs.165636

HS, PT

1.88 ± 0.54

NM_017594

DIRAS family, GTP-binding RAS-like 2

DIRAS2

0.00

0.00

NA

NA

Hs.198760

HS

8.37 ± 4.66

X15306

neurofilament, heavy polypeptide 200 kDa

NEFH

0.00

0.00

N

Y

Hs.233240

HS, PT

1.66 ± 0.60

NM_004369

collagen, type VI, alpha 3

COL6A3

0.03

0.11

Y

NA

Hs.235873

HS, PT

-1.61 ± 0.48

NM_024897

progestin and adipoQ receptor family member VI

PAQR6

0.01

0.08

NA

NA

Hs.277035

HS

1.48 ± 0.20

BC006230

monoglyceride lipase

MGLL

0.31

0.01

Y

NA

Hs.308709

HS

-2.22 ± 0.88

NM_005313

protein disulfide isomerase, family A, member 3

PDIA3

0.03

0.15

Y

NA

Hs.351279

HS, PT

1.90 ± 0.56

X76775

major histocompatibility complex, class II, DM alpha

HLA-DMA

0.02

0.01

N

NA

Hs.369397

HS, PT

1.63 ± 0.32

NM_000358

transforming growth factor, beta-induced, 68 kDa

TGFBI

0.05

0.00

Y

NA

Hs.378901

HS, PT

-1.49 ± 0.30

NM_014717

zinc finger protein 536

ZNF536

0.06

0.03

N

NA

Hs.412355

HS

1.82 ± 0.83

NM_001492

growth differentiation factor 1/LAG1 homolog, ceramide synthase 1

GDF1/LASS1

0.01

0.08

Y

NA

Hs.435557

HS, PT

-1.75 ± 0.39

BF059313

kinesin family member 5C

KIF5C

0.02

0.00

N

NA

Hs.443625

HS, PT

2.01 ± 0.63

NM_000090

collagen, type III, alpha 1 (Ehlers-Danlos syndrome type IV, autosomal dominant)

COL3A1

0.01

0.01

Y

NA

Hs.458573

HS, PT

1.47 ± 0.20

NM_006207

platelet-derived growth factor receptor-like

PDGFRL

0.15

0.00

Y

NA

Hs.478153

HS, PT

-1.62 ± 0.45

NM_005025

serpin peptidase inhibitor, clade I (neuroserpin), member 1

SERPINI1

0.03

0.14

Y

Y

Hs.483444

HS

1.60 ± 0.49

AF144103

chemokine (C-X-C motif) ligand 14

CXCL14

0.03

0.07

NA

NA

Hs.485130

HS

1.79 ± 0.52

NM_002121

major histocompatibility complex, class II, DP beta 1

HLA-DPB1

0.03

0.02

Y

NA

Hs.489142

HS, PT

1.62 ± 0.42

NM_000089

collagen, type I, alpha 2

COL1A2

0.03

0.01

Y

NA

Hs.48924

HS

-1.85 ± 0.46

NM_014782

armadillo repeat containing, X-linked 2

ARMCX2

0.03

0.03

Y

NA

Hs.496622

HS, PT

-1.80 ± 0.41

NM_005032

plastin 3 (T isoform)

PLS3

0.03

0.03

Y

NA

Hs.515354

HS

-1.73 ± 0.58

NM_002361

myelin-associated glycoprotein

MAG

0.05

0.23

Y

NA

Hs.515369

HS

1.77 ± 0.55

NM_003332

TYRO protein tyrosine kinase binding protein

TYROBP

0.03

0.14

N

NA

Hs.518525

HS

-1.60 ± 0.30

NM_002065

glutamate-ammonia ligase (glutamine synthetase)

GLUL

0.07

0.00

Y

NA

Hs.520048

HS

1.50 ± 0.56

M60333

major histocompatibility complex, class II, DR alpha

HLA-DRA

0.03

0.51

Y

NA

Hs.529571

HS, PT

1.63 ± 0.44

NM_002899

retinol binding protein 1, cellular

RBP1

0.02

0.03

Y

Y

Hs.550276

HS, PT

1.59 ± 0.23

NA

NA

NA

0.07

0.00

Y

NA

Hs.70327

HS

1.68 ± 0.38

NM_001311

cysteine-rich protein 1 (intestinal)

CRIP1

0.03

0.01

Y

NA

Hs.88778

HS, PT

-1.90 ± 0.44

BC002511

carbonyl reductase 1

CBR1

0.03

0.01

Y

NA

Hs.109225

PT

1.58 ± 1.42

NM_001078

vascular cell adhesion molecule 1

VCAM1

0.04

0.48

Y

NA

Hs.144197

PT

-1.74 ± 0.50

NM_003360

UDP glycosyltransferase 8 (UDP-galactose ceramide galactosyltransferase)

UGT8

0.02

0.06

N

NA

Hs.190495

PT

6.78 ± 4.64

NM_002510

glycoprotein (transmembrane) nmb

GPNMB

0.00

0.01

Y

Y

Hs.388664

PT

1.53 ± 0.50

NM_000975

ribosomal protein L11

RPL11

0.03

0.47

Y

NA

Hs.502235

PT

2.30 ± 1.03

NA

NA

NA

0.01

0.02

Y

Y

Hs.518773

PT

-2.22 ± 0.58

BF448062

ubiquitin-conjugating enzyme E2D 3 (UBC4/5 homolog, yeast)

UBE2D3

0.04

0.01

Y

NA

Hs.530902

PT

1.63 ± 0.42

NM_005849

immunoglobulin superfamily, member 6

IGSF6

0.10

0.02

N

NA

Hs.532768

PT

1.60 ± 0.39

NM_002615

pigment epithelium derived factor/serpin peptidase inhibitor, clade F, member 1

PEDF/SERPINF1

0.13

0.02

Y

NA

Hs.58414

PT

1.69 ± 0.63

NM_001458

filamin C, gamma (actin binding protein 280)

FLNC

0.04

0.09

Y

NA

Hs.75285

PT

1.49 ± 0.39

NM_002216

inter-alpha (globulin) inhibitor H2

ITIH2

0.05

0.03

N

NA

  1. 'Definition' indicates the species definitions used; 'HS' indicates human; 'PT' indicates chimpanzee. For transcripts identified by both definitions (e.g. NRN1), the data shown in the table was produced using the human definition. Fold change (i.e. fold increase or fold decrease) and standard error of fold change were calculated as described in Methods. 'RP' indicates p-values generated by Rank Products; 'SAM' indicates p-values generated by significance analysis of microarrays. 'ONH Astrocyte' and 'RGC' indicate probable expression in optic nerve head astrocytes and retinal ganglion cells, respectively (Methods); 'NA' indicates no data were available.